Advanced Magnetics Inc said it
reached a four mln dlrs research and development agreement with
ML TEchnolgy Ventures LP, a limited partnership sponsored by
Merrill LYnch Capital Markets.
    Under the agreement, Advanced Magnetics will develop and
conducts clinical trials of its contrast agents for magnetic
resonance imaging.
    The agreement includes a warrant permitting MLTV to buy up
to 380,000 shares of Advanced Magnetics common stock through
February 1994 at 10.50 dlrs per sahre.
 Reuter
&#3;